Altasciences

WebinarsPanel discussions

Patient Centricity and the Evolving Role of Microsampling

Bioanalysis by hybridization ELISA to support recent advances in the field of antisense oligonucleotides

Bioanalytical project management – a critical function adapted to the study type(s) of your drug development program

Harnessing bioanalytical data in early phase clinical pharmacology studies

Webinar Q&A follow up – Development of neutralizing antibody assays to support clinical safety assessment: when is a cell-based assay required and what challenges can you expect?

Development of neutralizing antibody assays to support clinical safety assessment: when is a cell-based assay required and what challenges can you expect?

Volumetric absorptive microsampling and impact-assisted extraction: have we finally eliminated the hematocrit effect?

Hybrid LBA-LC/MS assays for protein bioanalysis: a good idea for so many reasons

Panel discussion: gender parity in bioanalysis

Altasciences is a forward-thinking, mid-size contract research organization offering biopharma a proven, flexible approach to early drug development. With over 25 years of industry experience, Altasciences provides a full-service platform of preclinical and clinical solutions to help our clients reach critical decision making milestones sooner by improving ‘speed and ease’ from lead candidate selection to proof of concept.

Website: https://www.altasciences.com/

Email: [email protected]

Telephone: 1 450 973 6077

Address: 575 Armand Frappier, Laval, Quebec, H7V 4B3, Canada